The Duke Center for AIDS Research (CFAR) promotes the collaboration and coordination of AIDS-related research by supporting the scientific needs of the basic and clinical research community at Duke.
Formed in 2006 as part of Duke University’s commitment to spark innovation in global health research and education, the institute brings together knowledge and resources from across the university to address the most important global health issues of our time.
The Duke Human Vaccine Institute (DHVI) continues to lead with cutting edge vaccine research against infectious diseases that impact global health. The investigators at the DHVI conduct basic and translational research to develop novel vaccines, therapeutics and diagnostics for diseases such as HIV-1, tuberculosis, influenza, syphilis, gonorrhea, cytomegalovirus, rotavirus, parainfluenza, zika flavivirus, plague and now SARS-CoV-2.
The Department of Immunology serves as the focal point for immunological research and education at Duke in Durham, North Carolina. The organization of immunological research and education in a department rather than a program provides a tremendous advantage in that immunology has a physical home that facilitates interactions and builds cohesiveness among faculty, students, postdoctoral fellows, and staff.
The Department of Molecular Genetics and Microbiology resulted from the merger in 2002 of two existing departments, Microbiology and Genetics, and has two major areas of focus: genetics/genomics and microbiology.